Literature DB >> 17191255

Type I interferon response against viral and non-viral gene transfer in human tumor and primary cell lines.

Outi Rautsi1, Saara Lehmusvaara, Tuula Salonen, Katja Häkkinen, Maarit Sillanpää, Tanja Hakkarainen, Sami Heikkinen, Elisa Vähäkangas, Seppo Ylä-Herttuala, Ari Hinkkanen, Ilkka Julkunen, Jarmo Wahlfors, Riikka Pellinen.   

Abstract

BACKGROUND: Type I interferon (IFN-alpha/beta) response is one of the major host defence mechanisms against viruses. Some recent reports suggest that IFNs may interfere with the efficacy of both non-viral and virus-vector-mediated therapeutic gene transfer.
METHODS: The type I IFN response upon different gene transfer methods in human tumor and primary cell lines was studied by analysing IFN-beta mRNA expression, secretion of type I IFNs and accumulation of IFN-alpha/beta-induced MxA protein (myxovirus resistance protein A).
RESULTS: Infection with avirulent Semliki Forest virus A7[74] induced MxA protein accumulation and increased the IFN-beta mRNA level, whereas none of the studied virus vectors (adenovirus, CRAd, lentivirus or AAV) induced IFN response. However, plasmid DNA induced the accumulation of MxA protein when transfected with several commercial transfection reagents. RNA transfection appeared to be an efficient inducer of type I IFN response: replicating alphaviral RNA, eukaryotic total RNA, or mRNA all induced both MxA protein accumulation and IFN-beta expression. siRNA transfection failed to induce MxA response.
CONCLUSIONS: The non-viral gene transfer methods have gained more interest in recent years due to their better safety profiles when compared to their viral counterparts. However, the efficiency of non-viral gene transfer is well below those reached by viral vector systems. The type I interferon response induced by non-viral methods may in part contribute to this inefficiency, while most currently used viral gene transfer vectors fail to induce or are able to suppress type I IFN response. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17191255     DOI: 10.1002/jgm.997

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  4 in total

1.  Nucleofection of expression vectors induces a robust interferon response and inhibition of cell proliferation.

Authors:  Sandra Huerfano; Boris Ryabchenko; Jitka Forstová
Journal:  DNA Cell Biol       Date:  2013-06-08       Impact factor: 3.311

2.  A plasmid-based reverse genetics system for mammalian orthoreoviruses driven by a plasmid-encoded T7 RNA polymerase.

Authors:  Satoshi Komoto; Takahiro Kawagishi; Takeshi Kobayashi; Mine Ikizler; Jason Iskarpatyoti; Terence S Dermody; Koki Taniguchi
Journal:  J Virol Methods       Date:  2013-10-29       Impact factor: 2.014

3.  Specific inhibition of SRC kinase impairs malignant glioma growth in vitro and in vivo.

Authors:  Hanna Stedt; Laura Alasaarela; Haritha Samaranayake; Jere Pikkarainen; Ann-Marie Määttä; Ivana Kholová; Aaron S Parker; Seppo Ylä-Herttuala
Journal:  Mol Ther Nucleic Acids       Date:  2012-05-01       Impact factor: 10.183

Review 4.  Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope.

Authors:  Fatah Kashanchi; Reza Jafari; Cynthia Aslan; Seyed Hossein Kiaie; Naime Majidi Zolbanin; Parisa Lotfinejad; Reihaneh Ramezani
Journal:  BMC Biotechnol       Date:  2021-03-10       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.